Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HHS Nominee Azar: Great News For Industry But ACA Reform Will Be Priority

13 Nov 2017

• By Cathy Kelly

HHS Building_1200

Related Content

Trump Exec Order On Drug Costs: Seeking To Balance Access, Innovation

24 Jun 2017

HHS Leadership Upheaval Could Delay Initiatives Impacting Biopharma

30 Sep 2017

Drug Payment Experiments Coming To Medicare, Medicaid

21 Sep 2017

Lilly, Anthem Singing Same Tune On Value-Based Pricing, Communication Policy

09 Feb 2016

Related Companies

Eli Lilly and Company

Anthem Inc.

Additional Topics

United States Pricing Debate Government Payers Leadership Policy Medicaid Legislation BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.